Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership17 shares
Latest Disclosed Value $ 364
Signaturefd, Llc ownership in PDC / Pediatrix Medical Group, Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 17 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $306 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 17 shares of Pediatrix Medical Group, Inc.. The current value of the position is $318 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 17 0 0.00 0 0.0000
2026-01-20 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 17 0 0.00 0 0.0000
2025-10-21 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 17 17 0 0.0000
2024-10-21 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 0 -1,427 -100.00 0 -100.00
2024-07-29 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,427 -1,342 -48.47 11 -62.96 0.0002
2024-05-03 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,769 1,533 124.03 28 145.45 0.0006
2024-02-01 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,236 897 264.60 11 175.00 0.0003
2023-11-03 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 339 0 0.00 4 0.00 0.0001
2023-08-01 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 339 -1,106 -76.54 5 -80.95 0.0001
2023-04-28 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,445 1,086 302.51 22 320.00 0.0006
2023-01-30 2022-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 359 -28 -7.24 5 -16.67 0.0002
2022-11-08 2022-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 387 -89 -18.70 6 -40.00 0.0002
2022-08-10 2022-06-30 13F MEDNAX COM 58502B106 476 120 33.71 10 25.00 0.0003
2022-05-02 2022-03-31 13F MEDNAX COM 58502B106 356 17 5.01 8 -11.11 0.0002
2022-01-25 2021-12-31 13F MEDNAX COM 58502B106 339 0 0.00 9 -10.00 0.0003
2021-10-28 2021-09-30 13F MEDNAX COM 58502B106 339 0 0.00 10 0.00 0.0003
2021-07-26 2021-06-30 13F MEDNAX COM 58502B106 339 0 0.00 10 11.11 0.0004
2021-04-30 2021-03-31 13F MEDNAX COM 58502B106 339 0 0.00 9 12.50 0.0004
2021-02-11 2020-12-31 13F MEDNAX COM 58502B106 339 -65 -16.09 8 14.29 0.0004
2020-11-03 2020-09-30 13F MEDNAX COM 58502B106 404 65 19.17 7 16.67 0.0004
2020-07-30 2020-06-30 13F MEDNAX COM 58502B106 339 -326 -49.02 6 -25.00 0.0004
2020-04-23 2020-03-31 13F MEDNAX COM 58502B106 665 55 9.02 8 -52.94 0.0007
2020-02-05 2019-12-31 13F MEDNAX COM 58502B106 610 340 125.93 17 183.33 0.0013
2019-10-16 2019-09-30 13F MEDNAX COM 58502B106 270 -171 -38.78 6 -45.45 0.0005
2019-07-31 2019-06-30 13F MEDNAX COM 58502B106 441 -483 -52.27 11 -56.00 0.0010
2019-05-09 2019-03-31 13F MEDNAX COM 58502B106 924 82 9.74 25 -10.71 0.0021
2019-02-13 2018-12-31 13F MEDNAX COM 58502B106 842 503 148.38 28 75.00 0.0026
2018-11-14 2018-09-30 13F MEDNAX COM 58502B106 339 -89 -20.79 16 -15.79 0.0016
2018-08-14 2018-06-30 13F MEDNAX COM 58502B106 428 70 19.55 19 -5.00 0.0021
2018-05-08 2018-03-31 13F MEDNAX COM 58502B106 358 358 20 0.0023
2017-02-14 2016-12-31 13F MEDNAX COM 58502B106 0 -223 -100.00 0 -100.00
2016-11-14 2016-09-30 13F MEDNAX COM 58502B106 223 0 0.00 15 -6.25 0.0022
2016-07-29 2016-06-30 13F MEDNAX COM 58502B106 223 23 11.50 16 23.08 0.0023
2016-05-12 2016-03-31 13F MEDNAX COM 58502B106 200 -57 -22.18 13 -27.78 0.0022
2016-01-22 2015-12-31 13F MEDNAX COM 58502B106 257 57 28.50 18 20.00 0.0035
2015-10-23 2015-09-30 13F MEDNAX COM 58502B106 200 0 0.00 15 0.00 0.0034
2015-07-15 2015-06-30 13F MEDNAX COM 58502B106 200 0 0.00 15 0.00 0.0033
2015-04-15 2015-03-31 13F MEDNAX COM 58502B106 200 0 0.00 15 15.38 0.0036
2015-02-13 2014-12-31 13F MEDNAX COM 58502B106 200 200 13 0.0032
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.